Completed NA INTERVENTIONAL 2-arm NCT04130321

Demonstration of the Prebiotic-like Effects of Camu-camu Consumption Against Obesity-related Disorders in Humans

Sponsor: Laval University

Conditions Endotoxemia Insulin Resistance Metabolic Syndrome Microtia Non-Alcoholic Fatty Liver Disease Overweight

Updated 9 times since 2019 Last updated: Oct 3, 2022 Started: Oct 31, 2020 Primary completion: Apr 21, 2022 Completion: Apr 21, 2022

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Listed as NCT04130321, this NA trial focuses on Endotoxemia and Insulin Resistance and remains completed. Sponsored by Laval University, it has been updated 9 times since 2020, reflecting limited change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.

Status Flow

Change History

9 versions recorded

Sep 2024 — Present [monthly]

Completed NA
Jul 2024 — Sep 2024 [monthly]

Completed NA
Nov 2022 — Jul 2024 [monthly]

Completed NA

Status: Active Not Recruiting → Completed
Sep 2021 — Nov 2022 [monthly]

Active Not Recruiting NA

Status: Recruiting → Active Not Recruiting
Mar 2021 — Sep 2021 [monthly]

Recruiting NA

Status: Not Yet Recruiting → Recruiting

▶ Show 4 earlier versions

Jan 2021 — Mar 2021 [monthly]

Not Yet Recruiting NA
Nov 2020 — Jan 2021 [monthly]

Not Yet Recruiting NA
Apr 2020 — Nov 2020 [monthly]

Not Yet Recruiting NA
Nov 2019 — Apr 2020 [monthly]

Not Yet Recruiting NA

First recorded

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Laval University

Data source: Laval University

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Québec, Canada